Article Correctness Is Author's Responsibility: FDA Phase 1 Trial Shows Hydrogel to Repair Heart Is Safe to Inject in Humans–a First

Newswise imageVentrix, a University of California San Diego spin-off company, has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack.